There are currently more than 1.2 million people living with the human immunodeficiency virus (HIV) in the United States, with more than 56,000 new infections annually. The understanding and management of HIV disease among patients in unique populations—such as the aging person with HIV, the HIV/HCV coinfected patient, the young man of color who has sex with men, and the patient who presents with advanced disease—are continually evolving. In this continuing medical education activity, distinguished faculty presenters will provide program participants with case studies demonstrating the clinical application of the most recent data and guidelines for the differentiation, evaluation, and identification of the best antiretroviral regimens for the aging patient with HIV, the patient with HIV/HCV coinfection, and patients presenting with advanced HIV disease. This activity will also provide program participants with the most recent data and guidelines for identifying barriers to prevention of HIV infection among young men of color who have sex with men and will suggest strategies to minimize biased self-reporting of sexual behaviors in this population in order to limit late diagnosis and delayed treatment.

This activity has been designed to meet the educational needs of clinicians who care for patients with HIV, including physicians, physician assistants, nurse practitioners, and nurses.

Upon completion of the activity, participants should be better able to:

• Explain the importance of diagnosing HIV in patients in unique populations
  
• Specify how aging and HIV infection increase a patient’s risk for developing cardiovascular disease
  
• Explain the importance of screening all HIV-infected patients for HCV coinfection
  
• Describe the goals of HCV therapy in patients coinfected with the HIV virus
  
• Outline the safety and efficacy profiles of available therapies
  
• Identify the risk factors and barriers to prevention, testing, and treatment of HIV infection among young men of color who have sex with men
  
• Outline effective treatment strategies for patients with advanced HIV disease

Sally L. Hodder, MD
Professor of Medicine
New Jersey Medical School
University of Medicine and Dentistry of New Jersey
Newark, NJ

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and HealthmattersCME. PIM is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Postgraduate Institute for Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNA/ANCC

This educational activity for 1.0 contact hour is provided by Postgraduate Institute for Medicine (PIM).

PIM is an approved provider of continuing nursing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

California Board of Registered Nursing

Postgraduate Institute for Medicine is approved by the California Board of Registered Nursing, Provider Number 13485, for 1.4 contact hour.

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PIM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

FACULTY DISCLOSURES

Sally L. Hodder, MD
Grant/Research Support: Bristol-Myers Squibb, Gilead Sciences, Tibotec, Scientifc
Advisory Board: Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Tibotec
Speakers Bureau: Bristol-Myers Squibb

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity

Linda Graham, RN, BSN, BA (PIM)
No financial interest/relationships with commercial interests relating to the topic of this activity

Jan Hixon, RN, BSN, MA (PIM)
No financial interest/relationships with commercial interests relating to the topic of this activity

Trace Hutchison, PharmD (PIM)
No financial interest/relationships with commercial interests relating to the topic of this activity

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM), HealthmattersCME, and Gilead Sciences Medical Affairs do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, HealthmattersCME, and Gilead Sciences Medical Affairs. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

• Please go online to http://www.peermeetings.com/hmc/08625H and complete the posttest, evaluation and credit request in order to receive CME/CE credit for the Profiles in HIV: In-Depth Analyses and Case Studies of Special Populations Living with HIV webcast.
• You will be able to print out your certificate upon notification that you have passed the posttest.
• Log in or register for a free account
• If you encounter any challenges connecting to the CME/CE evaluation/application Web page, please contact Ms Alexis Weinstein at HealthmattersCME, 646-674-1820, X246, or aweinstein@contacthmc.com.

There are no fees for participating and receiving CME credit for this activity. During the period March, 2009 through March, 2010, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) please go online to http://www.peermeetings.com/hmc/08625H and complete the posttest, evaluation and credit request in order to receive CME/CE credit for the Profiles in HIV: In-Depth Analyses and Case Studies of Special Populations Living with HIV webcast. You will be able to print out your certificate upon notification that you have passed the posttest with a score of 70% or better.

• Internet Activity